Chronic Environmental and Occupational Lead Exposure and Kidney Function among African Americans: Dallas Lead Project II
Abstract
:1. Introduction
2. Study Population and Methods
2.1. Population Background
2.2. Study Design
2.3. Estimated Glomerular Filtration Rate (eGFR)
2.4. Analysis
2.5. Software
3. Results
4. Discussion
5. Conclusions
Supplementary Materials
Author Contributions
Funding
Acknowledgments
Conflicts of Interest
References
- Brewster, U.C.; Perazella, M.A. A review of chronic lead intoxication: An unrecognized cause of chronic kidney disease. Am. J. Med. Sci. 2004, 327, 341–347. [Google Scholar] [CrossRef] [PubMed]
- Evans, M.; Elinder, C.-G. Chronic renal failure from lead: Myth or evidence-based fact. Kidney Int. 2011, 79, 272–279. [Google Scholar] [CrossRef] [PubMed]
- Ekong, E.B.; Jaar, B.G.; Weaver, V.M. Lead-related nephrotoxicity: A review of the epidemiologic evidence. Kidney Int. 2006, 70, 2074–2084. [Google Scholar] [CrossRef] [PubMed]
- Loghman-Adham, M. Renal effects of environmental and occupational lead exposure. Environ. Health Perspect. 1997, 105, 928–938. [Google Scholar] [CrossRef] [PubMed]
- Wedeen, R.P.; Maesaka, J.K.; Weiner, B.; Lipat, G.A.; Lyons, M.M.; Vitale, L.F.; Joselow, M.M. Occupational lead nephropathy. Am. J. Med. 1975, 59, 630–641. [Google Scholar] [CrossRef]
- Wedeen, R.P.; Mallik, D.K.; Batuman, V. Detection and treatment of occupational lead nephropathy. Arch. Intern. Med. 1979, 139, 53–57. [Google Scholar] [CrossRef]
- Gerhardsson, L.; Chettle, D.R.; Englyst, V.; Nordberg, G.F.; Nyhlin, H.; Scott, M.C.; Todd, A.C.; Vesterberg, O. Kidney effects in long term exposed lead smelter workers. Br. J. Ind. Med. 1992, 49, 186–192. [Google Scholar] [CrossRef] [PubMed]
- Marsden, P.A. Increased body lead burden- cause or consequence of chronic renal insufficiency? N. Engl. J. Med. 2003, 348, 345–347. [Google Scholar] [CrossRef]
- Wedeen, R.P. Lead Nephropathy. In Clinical Nephrotoxins; De Broe, M.E., Porter, G.A., Bennett, W.M., Deray, G., Eds.; Springer: New York, NY, USA, 2008; pp. 773–783. [Google Scholar]
- Little, B.B.; Spalding, S.; Walsh, B.; Keyes, D.C.; Wainer, J.; Pickens, S.; Royster, M.; Villanacci, J.; Gratton, T. Blood lead levels and growth status among African-American and Hispanic children in Dallas, Texas-1980 and 2002: Dallas Lead Project II. Ann. Hum. Biol. 2009, 36, 331–341. [Google Scholar] [CrossRef]
- United States Environmental Protection Agency. Available online: http://www.epa.gov/superfund/sites/rods/fulltext/r0695096.pdf (accessed on 12 September 2018).
- Levey, A.S.; Bosch, J.P.; Lewis, J.B.; Greene, T.; Rogers, N.; Roth, D. A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Ann. Intern. Med. 1999, 130, 461–470. [Google Scholar] [CrossRef]
- Muntner, P.; He, J.; Vupputuri, S.; Coresh, J.; Batuman, V. Blood lead and chronic kidney disease in the general United States population: Results from NHANES II. Kidney Int. 2003, 63, 1044–1050. [Google Scholar] [CrossRef] [PubMed]
- Staessen, J.A.; Lauwerys, R.R.; Buchet, J.P.; Bulpitt, C.J.; Rondia, D.; Vanrenterghem, Y.; Amery, A. Impairment of renal function with increasing blood lead concentrations in the general population. The Cadmibel Study Group. N. Engl. J. Med. 1992, 327, 151–156. [Google Scholar] [CrossRef] [PubMed]
- Muntner, P.; Menke, A.; DeSalvo, K.B.; Rabito, F.A.; Batuman, V. Continued decline in blood lead levels among adults in the United States. The National Health and Nutrition Examination Surveys. Arch. Intern. Med. 2005, 165, 2155–2161. [Google Scholar] [CrossRef] [PubMed]
- Staessen, J.; Yeoman, W.B.; Fletcher, A.E.; Markowe, H.L.; Marmot, M.G.; Rose, G.; Semmence, A.; Shipley, M.J.; Bulpitt, C.J. Blood lead concentration, renal function, and blood pressure in London civil servants. Br. J. Ind. Med. 1990, 47, 442–447. [Google Scholar] [CrossRef] [PubMed]
- Payton, M.; Hu, H.; Sparrow, D.; Weiss, S.T. Low-level lead exposure and renal function in the Normative Aging Study. Am. J. Epidemiol. 1994, 140, 821–829. [Google Scholar] [CrossRef]
- Kim, R.; Rotnitsky, A.; Sparrow, D.; Weiss, S.; Wager, C.; Hu, H. A longitudinal study of low-level lead exposure and impairment of renal function. The Normative Aging Study. JAMA 1996, 275, 1177–1181. [Google Scholar] [CrossRef]
- Tsaih, S.W.; Korrick, S.; Schwartz, J.; Amarasiriwardena, C.; Aro, A.; Sparrow, D.; Hu, H. Lead, diabetes, hypertension, and renal function: The normative aging study. Environ. Health Perspect. 2004, 112, 1178–1182. [Google Scholar] [CrossRef]
- Navas-Acien, A.; Tellez-Plaza, M.; Guallar, E.; Muntner, P.; Silbergeld, E.; Jaar, B.; Weaver, V. Blood cadmium and lead and chronic kidney disease in US adults: A joint analysis. Am. J. Epidemiol. 2009, 170, 1156–1164. [Google Scholar] [CrossRef]
- Spector, J.T.; Navas-Acien, A.; Fadrowski, J.; Guallar, E.; Jaar, B.; Weaver, V.M. Associations of blood lead with estimated glomerular filtration rate using MDRD, CKD-EPI and serum cystatin C-based equations. Nephrol. Dial. Transplant. 2011, 26, 2786–2792. [Google Scholar] [CrossRef] [Green Version]
- Yu, C.C.; Lin, J.L.; Lin-Tan, D.T. Environmental exposure to lead and progression of chronic renal diseases: A four-year prospective longitudinal study. J. Am. Soc. Nephrol. 2004, 15, 1016–1022. [Google Scholar] [CrossRef]
- Little, B.B.; Snell, L.M.; Johnston, W.L.; Knoll, K.A.; Buschang, P.H. Blood lead levels and growth status of children. Am. J. Hum. Biol. 1990, 2, 265–269. [Google Scholar] [CrossRef]
- Gratton, T.B.; Trieff, N.M.; Aubespin, S.; Juarez, D. A review of health and environmental lead data from a neighborhood exposed to smelter emissions. J. Children’s Health 2004, 2, 21–27. [Google Scholar] [CrossRef]
- Theppeang, K.; Glass, T.A.; Bandeen-Roche, K.; Todd, A.C.; Rohde, C.A.; Schwartz, B.S. Gender and race/ethnicity differences in lead dose biomarkers. Am. J. Public Health 2008, 98, 1248–1255. [Google Scholar] [CrossRef]
- Cooper, W.C. Deaths from chronic renal disease in U.S. battery and lead production workers. Environ. Health Perspect. 1988, 78, 61–63. [Google Scholar] [CrossRef] [PubMed]
- Selevan, S.G.; Landrigan, P.J.; Stern, F.B.; Jones, J.H. Mortality of lead smelter workers. Am. J. Epidemiol. 1985, 122, 673–683. [Google Scholar] [CrossRef] [PubMed]
- Cooper, W.C.; Gaffey, W.R. Mortality of lead workers. J. Occup. Med. 1975, 17, 100–107. [Google Scholar] [CrossRef]
- Malcolm, D.; Barnett, H.A.R. A mortality study of lead workers 1925–1976. Br. J. Ind. Med. 1982, 39, 404–410. [Google Scholar]
- Davies, J.M. Long term mortality study of chromate pigment workers who suffered lead poisoning. Br. J. Ind. Med. 1984, 41, 170–178. [Google Scholar] [CrossRef]
- McMichael, A.J.; Johnson, H.M. Long-term mortality profile of heavily exposed lead smelter workers. J. Occup. Med. 1982, 24, 375–378. [Google Scholar] [CrossRef]
- Fanning, D. A mortality study of lead workers, 1926–1985. Arch. Environ. Health 1988, 43, 247–251. [Google Scholar] [CrossRef]
- Gerhardsson, L.; Lundström, N.G.; Nordberg, G.; Wall, S. Mortality and lead exposure: A retrospective cohort study of Swedish smelter workers. Br. J. Ind. Med. 1986, 43, 707–712. [Google Scholar] [CrossRef] [PubMed]
- Gennart, J.-P.; Bernard, A.; Lauwerys, R. Assessment of thyroid, testes, kidney and autonomic nervous system function in lead-exposed workers. Int. Arch. Occup. Environ. Health 1992, 64, 49–57. [Google Scholar] [CrossRef] [PubMed]
- Weaver, V.M.; Lee, B.-K.; Ahn, K.-D.; Lee, G.S.; Todd, A.C.; Stewart, W.F.; Wen, J.; Simon, D.J.; Parsons, P.J.; Schwartz, B.S. Associations of lead biomarkers with renal function in Korean lead workers. Occup. Environ. Med. 2003, 60, 551–562. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Oktem, F.; Arslan, M.K.; Dündar, B.; Delibas, N.; Gültepe, M.; Ergürhan Ilhan, I. Renal effects and erythrocyte oxidative stress in long-term low-level lead-exposed adolescent workers in auto repair workshops. Arch. Toxicol. 2004, 78, 681–687. [Google Scholar] [CrossRef] [PubMed]
- Baker, E.L.; Landrigan, P.J.; Barbour, A.G.; Cox, D.H.; Folland, D.S.; Ligo, R.N.; Throckmorton, J. Occupational lead poisoning in the United States: Clinical and biochemical findings related to blood lead levels. Br. J. Ind. Med. 1979, 36, 314–322. [Google Scholar] [CrossRef] [PubMed]
- Pinto de Almeida, A.R.; Carvalho, F.M.; Spinola, A.G.; Rocha, H. Renal dysfunction in Brazilian lead workers. Am. J. Nephrol. 1987, 7, 455–458. [Google Scholar] [CrossRef] [PubMed]
- Chia, K.S.; Jeyaratnam, J.; Tan, C.; Ong, H.Y.; Ong, C.N.; Lee, E. Glomerular function of lead-exposed workers. Toxicol. Lett. 1995, 77, 319–328. [Google Scholar] [CrossRef]
- Greenberg, A.; Parkinson, D.K.; Fetterolf, D.E.; Puschett, J.B.; Ellis, K.J.; Wielopolski, L.; Vaswani, A.N.; Cohn, S.H.; Landrigan, P.J. Effects of elevated lead and cadmium burdens on renal function and calcium metabolism. Arch. Environ. Health 1986, 41, 69–76. [Google Scholar] [CrossRef]
- Lilis, R.; Fischbein, A.; Valciukas, J.A.; Blumberg, W.; Selikoff, I.J. Kidney function and lead: Relationships in several occupational groups with different levels of exposure. Am. J. Ind. Med. 1980, 1, 405–412. [Google Scholar] [CrossRef]
- Verschoor, M.; Wibowo, A.; Herber, R.; van Hemmen, J.; Zielhuis, R. Influence of occupational low-level lead exposure on renal parameters. Am. J. Ind. Med. 1987, 12, 341–351. [Google Scholar] [CrossRef]
- Buchet, J.P.; Roels, H.; Bernard, A.; Lauwerys, R. Assessment of renal function of workers simultaneously exposed to inorganic lead and cadmium. J. Occup. Med. 1981, 23, 348–352. [Google Scholar]
- Ehrlich, R.; Robins, T.; Jordaan, E.; Miller, S.; Mbuli, S.; Selby, P.; Wynchank, S.; Cantrell, A.; De Broe, M.; D’Haese, P.; et al. Lead absorption and renal dysfunction in a South African battery factory. Occup. Environ. Med. 1998, 55, 453–460. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- dos Santos, A.C.; Colacciopo, S.; Dal Bó, C.M.; dos Santos, N.A. Occupational exposure to lead, kidney function tests, and blood pressure. Am. J. Ind. Med. 1994, 26, 635–643. [Google Scholar] [CrossRef] [PubMed]
- Omae, K.; Sakurai, H.; Higashi, T.; Muto, T.; Ichikawa, M.; Sasaki, N. No adverse effects of lead on renal function in lead-exposed workers. Ind. Health 1990, 28, 77–83. [Google Scholar] [CrossRef]
- Van de Vyver, F.L.; D’Haese, P.C.; Visser, W.J.; Elseviers, M.M.; Knippenberg, L.J.; Lamberts, L.V.; Wedeen, R.P.; De Broe, M.E. Bone lead in dialysis patients. Kidney Int. 1988, 33, 601–607. [Google Scholar] [CrossRef] [PubMed]
- Alves, T.P.; Lewis, J. Racial differences in chronic kidney disease (CKD) and (ESRD) in the United States: A social and economic dilemma. Clin. Nephrol. 2010, 74, S72–S77. [Google Scholar]
- Rabin, R. The lead industry and lead water pipes “A. Modest Campaign”. Am. J. Public Health 2008, 98, 1584–1592. [Google Scholar] [CrossRef] [PubMed]
- Bellinger, D.C. Lead Contamination in Flint—An abject failure to protect public health. N. Engl. J. Med. 2016, 374, 1101–1103. [Google Scholar] [CrossRef] [PubMed]
- Hanna-Attisha, M.; LaChance, J.; Sadler, R.C.; Champney Schnepp, A. Elevated blood lead levels in children associated with the Flint drinking water crisis: A spatial analysis of risk and public health response. Am. J. Public Health 2016, 106, 283–290. [Google Scholar] [CrossRef]
- Noborisaka, Y. Smoking and chronic kidney disease in healthy populations. Nephrourol. Mon. 2013, 5, 655–667. [Google Scholar] [CrossRef]
- Pinto-Sietsma, S.-J.; Mulder, J.; Janssen, W.M.T.; Hillege, H.L.; de Zeeuw, D.; de Jong, P.E. Smoking is related to albuminuria and abnormal renal function in nondiabetic persons. Ann. Intern. Med. 2000, 133, 585–591. [Google Scholar] [CrossRef]
- Yoon, H.J.; Park, M.; Yoon, H.; Son, K.Y.; Cho, B.; Kim, S. The differential effect of cigarette smoking on glomerular filtration rate and proteinuria in an apparently healthy population. Hypertens. Res. 2009, 32, 214–219. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Halimi, J.M.; Philippon, C.; Mimran, A. Contrasting renal effects of nicotine in smokers and non-smokers. Nephrol. Dial. Transplant. 1998, 13, 940–944. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Facchini, F.S.; Hollenbeck, C.B.; Jeppesen, J.; Chen, Y.D.; Reaven, G.M. Insulin resistance and cigarette smoking. Lancet 1992, 339, 1128–1130. [Google Scholar] [CrossRef]
- ter Maaten, J.C.; Bakker, S.J.; Serné, E.H.; ter Wee, P.M.; Donker, A.J.; Gans, R.O. Insulin’s acute effects on glomerular filtration rate correlate with insulin sensitivity whereas insulin’s acute effects on proximal tubular sodium reabsorption correlation with salt sensitivity in normal subjects. Nephrol. Dial. Transplant. 1999, 14, 2357–2363. [Google Scholar] [CrossRef] [PubMed]
Interquartile Range | |||||
---|---|---|---|---|---|
Total Sample | N | Mean | SD | 25th | 75th |
Age (years) | 778 | 46.9 | 14.5 | 36 | 57 |
Duration of residence (years) | 19.4 | 13.4 | 9 | 27 | |
Blood Lead (µg/dL) | 2.2 | 2.2 | 1 | 3 | |
Creatinine (mg/dL) | 1.04 | 0.53 | 0.9 | 1.1 | |
eGFR (mL/min/1.73 m2) | 91.4 | 24.1 | 76.4 | 105.4 | |
Diabetes ** | 117 | 15.00% | |||
Hypertension *** | 568 | 73.00% | |||
Smoke Tobacco | 230 | 29.50% | |||
Male, Resident: | |||||
Age (years) | 290 | 43 | 14.1 | 33 | 48.8 |
Duration of residence (years) | 11.5 | 11.9 | 0 | 24 | |
Blood Lead (µg/dL) | 2.7 | 2.5 | 1 | 3 | |
Creatinine (mg/dL) | 1.2 | 0.66 | 1 | 1.2 | |
eGFR (mL/min/1.73 m2) | 96 | 24.20% | 84.3 | 108.7 | |
Diabetes ** | 23 | 7.90% | |||
Hypertension *** | 172 | 59.30% | |||
Smoke Tobacco | 104 | 36.00% | |||
Female, Resident: | |||||
Age (years) | 436 | 47.7 | 14.3 | 25.3 | 54 |
Duration of residence (years) | 13.1 | 12.9 | 10 | 24 | |
Blood Lead (µg/dL) | 1.8 | 1.4 | 1 | 2 | |
Creatinine (mg/dL) | 0.94 | 0.41 | 1 | 1.2 | |
eGFR (mL/min/1.73 m2) | 89.8 | 23.3 | 76.5 | 102.2 | |
Diabetes ** | 82 | 18.80% | |||
Hypertension *** | 356 | 81.70% | |||
Smoke Tobacco | 104 | 23.80% | |||
Male, Smelter-working resident: | |||||
Age (years) | 52 | 55.8 | 10.5 | 48 | 64 |
Duration of residence (years) | 14.1 | 12.2 | 7.3 | 30.8 | |
Blood Lead (µg/dL) | 4.5 | 5 | 2 | 5 | |
Creatinine (mg/dL) | 1.3 | 0.67 | 1 | 1.4 | |
eGFR (mL/min/1.73 m2) | 85.2 | 26.5 | 68.5 | 103.2 | |
Diabetes ** | 12 | 23.10% | |||
Hypertension *** | 40 | 76.90% | |||
Smoke Tobacco | 28 | 53.80% |
GFR Units Scaled | N | B | SE | p | eGFR Decrement per 10 μg/dL ↑ Pb |
---|---|---|---|---|---|
Total Sample | |||||
Log blood lead | 778 | −22.84 | 3.85 | 0.0001 | −22.8 mL/min/1.73 m2 |
Duration of residence | −0.11 | 0.07 | 0.11 | ||
Diabetes | −7.42 | 2.42 | 0.002 | ||
Hypertension | −8.08 | 1.9 | 0.0001 | ||
Smoking Tobacco | 7.9 | 0.99 | 0.0001 | ||
Intercept | 107.67 | 2.29 | 0.0001 | ||
Male: Resident | |||||
Log blood lead | 290 | −21.19 | 7.15 | 0.003 | −21.2 mL/min/1.73 m2 |
Duration of residence | 0.04 | 0.13 | 0.75 | ||
Diabetes | −1.36 | 5.47 | 0.8 | ||
Hypertension | −5.87 | 3.47 | 0.09 | ||
Smoking Tobacco | 9.95 | 3.51 | 0.005 | ||
Intercept | 106.39 | 4.47 | 0.0001 | ||
Female: Resident | |||||
Log blood lead | 436 | −25.27 | 5.07 | 0.0001 | −25.3 mL/min/1.73 m2 |
Duration of residence | −0.10 | 0.08 | 0.22 | ||
Diabetes | −8.40 | 2.82 | 0.003 | ||
Hypertension | −9.46 | 2.29 | 0.0001 | ||
Smoking Tobacco | 4.22 | 2.59 | 0.11 | ||
Intercept | 107.83 | 2.74 | 0.0001 | ||
Male: Smelter Worker | |||||
Log blood lead | 52 | −59.16 | 13.64 | 0.0001 | −59.2 mL/min/1.73 m2 |
Duration of residence | −0.54 | 0.23 | 0.03 | ||
Diabetes | −9.09 | 7.98 | 0.26 | ||
Hypertension | −0.90 | 9.16 | 0.92 | ||
Smoke Tobacco | 13.11 | 7.18 | 0.08 | ||
Intercept | 133.98 | 15.14 | 0.0001 |
© 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Share and Cite
Reilly, R.; Spalding, S.; Walsh, B.; Wainer, J.; Pickens, S.; Royster, M.; Villanacci, J.; Little, B.B. Chronic Environmental and Occupational Lead Exposure and Kidney Function among African Americans: Dallas Lead Project II. Int. J. Environ. Res. Public Health 2018, 15, 2875. https://doi.org/10.3390/ijerph15122875
Reilly R, Spalding S, Walsh B, Wainer J, Pickens S, Royster M, Villanacci J, Little BB. Chronic Environmental and Occupational Lead Exposure and Kidney Function among African Americans: Dallas Lead Project II. International Journal of Environmental Research and Public Health. 2018; 15(12):2875. https://doi.org/10.3390/ijerph15122875
Chicago/Turabian StyleReilly, Robert, Susan Spalding, Brad Walsh, Jeanne Wainer, Sue Pickens, Marcene Royster, John Villanacci, and Bert B. Little. 2018. "Chronic Environmental and Occupational Lead Exposure and Kidney Function among African Americans: Dallas Lead Project II" International Journal of Environmental Research and Public Health 15, no. 12: 2875. https://doi.org/10.3390/ijerph15122875
APA StyleReilly, R., Spalding, S., Walsh, B., Wainer, J., Pickens, S., Royster, M., Villanacci, J., & Little, B. B. (2018). Chronic Environmental and Occupational Lead Exposure and Kidney Function among African Americans: Dallas Lead Project II. International Journal of Environmental Research and Public Health, 15(12), 2875. https://doi.org/10.3390/ijerph15122875